Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.
Health officials simplify pneumococcal vaccine guidance
By
Alicia Lasek
Jan 31, 2022
The CDC has published revised recommendations for pneumococcal vaccination in the elderly and immunocompromised following a vote by its immunization advisors.
Advice from healthcare providers increases vaccination rates, new study finds
By
Alicia Lasek
Dec 17, 2021
A nudge from a healthcare provider makes a big difference in who is likely to get vaccinated, new evidence reveals.
Clinical briefs for Thursday, Dec. 16
By
Alicia Lasek
Dec 16, 2021
All three U.S.-authorized vaccines less effective against omicron without booster … Federal court reinstates CMS vaccine mandate in 26 states … Idaho officials: 1 in 4 COVID deaths were in nursing...
Receipt of herpes, Tdap vaccines associated with lower risk of dementia in older adults: study
By
Amy Novotney
Dec 14, 2021
Older adults who receive the herpes zoster (HZ), and tetanus, diphtheria, pertussis (Tdap) vaccinations are less likely to develop Alzheimer’s disease, according to research by scientists at St. Louis...
Providers embracing reprieve as staff vaccine deadline passes unenforced
By
Kimberly Marselas
Dec 09, 2021
Skilled nursing providers with large shares of their workforce still unvaccinated nearly a year after COVID-19 vaccines first became available are breathing sighs of relief across the country this week.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
‘How good are those vaccines now?’ Mixed AARP nursing home report prompts a thorny question
By
Alicia Lasek
Nov 15, 2021
A new AARP report shows encouraging trends in COVID-19 cases and vaccinations. But the steady rate of resident deaths raises concerns for the future as vaccine efficacy wanes, analysts say.
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...
FDA panel recommends COVID boosters for older adults, healthcare workers
By
Kimberly Bonvissuto
Sep 20, 2021
An FDA advisory panel has unanimously recommended approving COVID-19 booster shots for adults aged 65 years and older and for individuals at high risk of severe disease, including healthcare workers.